Abstract
changes in the levels of glucose utilization in tumors during the course of chemotherapy has led to the investigation of FDGPET as a prognostic indicator of response to chemotherapy.3 The ability to detect nonresponsive tumors early in the course of therapy may avoid unnecessary treatmentrelated toxicity and allow early modification of therapy in the hopes of achieving tumor response.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
